المؤلفون: Ozkanli, Gulhan, Duman, Berna Bozkurt, Aydin, Dincer, Dulgar, Ozgecan, Er, Muhammed Muhiddin, Teker, Fatih, Yavuzsen, Tugba, Aykan, Musa Baris, Inal, Ali, Iriagac, Yakup, Kalkan, Nurhan Onal, Keser, Murat, Kut, Engin, Bilgin, Burak, Karaoglanoglu, Muge, Ozdemir, Ozlem, Turhal, Nazim Serdar, Karadurmus, Nuri, Yalcin, Bulent, Sendur, Mehmet Ali Nahit, Paydas, Semra, Kahraman, Seda, Erul, Enes, Seyyar, Mustafa, Gümüşay, Özge, Bayram, ErtuÄŸrul, Acar, Ömer, Aksoy, Sercan, Baytemur, Naziyet Kose, Sahin, Elif, Cabuk, Devrim, Basaran, Gül, Guven, Deniz Can, Erdogan, Atike Pinar, Demirci, Umut, Yasar, Alper, Bayoglu, Ibrahim Vedat, Hizal, Mutlu, Gulbagci, Burcu, Paksoy, Nail, Yilmaz, Funda, Dogan, Ozlem, Orhan, Sibel Oyucu, Kayikcioglu, Erkan, Aytac, Ali, Unal, Olcun Umit, Demir, Hacer, Erol, Cihan, Selcukbiricik, Fatih, Sakalar, Teoman, Sunar, Veli, Keskinkilic, Merve, Mocan, Eda Eylemer, Aydin, Esra, Yucel, Hakan, Isik, Deniz, Eren, Onder, Uluc, Basak Oyan, Ozcelik, Melike, Hacibekiroglu, Ilhan, Aydiner, Adnan, Oksuzoglu, Berna, Cilbir, Ebru, Cubukcu, Erdem, Cetin, Bulent, Oktay, Esin, Okutur, Sadi Kerem, Yildirim, Nilgun, Alkan, Ali, Aksoy, Asude, Karakas, Yusuf, Çakan Demirel, Burçin, Yaren, Arzu

مصطلحات موضوعية: CDK 4, 6 inhibitors, HER2-negative metastatic breast cancer, HR-positive, letrozole

العلاقة: Future Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.2217/fon-2022-1287Test; https://hdl.handle.net/11499/51149Test; 2-s2.0-85159731947; WOS:000991646700001

الإتاحة: https://doi.org/10.2217/fon-2022-1287Test
https://hdl.handle.net/11499/51149Test

المؤلفون: Yıldız, Fatih, Demirci, Umut, Küçükard, Ahmet, BüyükÅŸimsek, Mahmut, Gümüşay, Özge, Sakalar,Teoman, Topçu, Turkan, Aslan, Ferit, Tufan, Gülnihal, Aydın, Övgü, Turna, Hande, Babacan, Nalan, BaÅŸoÄŸlu, TuÄŸba, Kurt, Bediz, Yıldız, Birol, Eren, Tülay, Demiray, Atike, Arslan, ÇaÄŸatay, Özdemir, Nuriye, Ãœrün, Yüksel, Baykara, Meltem, Turan, Nedim, Uysal, Mükremin, Kavgacı, Halil, Cicin, Ä°rfan, Kılıçkap, Saadettin, Bilici, Ahmet, PaydaÅŸ, Semra

مصطلحات موضوعية: overall survival, progression free survival, aftercare, CK20, merkel cell carcinoma, neuroendocrin carcinoma, skin carcinoma, avelumab, carboplatin, cisplatin, cyclophosphamide, cytokeratin 20, doxorubicin, etoposide, vincristine, adjuvant radiotherapy, adult, aged, Article, cancer adjuvant therapy, cancer combination chemotherapy, cancer radiotherapy, cancer recurrence, cancer staging, cancer survival, chemoradiotherapy, clinical evaluation, disease free survival, distant metastasis, female

العلاقة: Journal of Cancer Research and Therapeutics; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.4103/jcrt.JCRT-950-19Test; https://hdl.handle.net/11499/47804Test; 17; 1525; 1529; 2-s2.0-85121898572

الإتاحة: https://doi.org/10.4103/jcrt.JCRT-950-19Test
https://hdl.handle.net/11499/47804Test